PATENT CLAIM ANALYSIS

Application Number: 15925260
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "001110"]

Abstract:
The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.

Claim (Index 10):
The method according to  claim 8 , wherein the step of topically administering comprising topically administering at intervals of treatment time points to produce higher drug concentrations in the at least one nasolacrimal duct for each treatment time point.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 90.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11112553', '14225087', '12012469', '13962509', '15099034']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8107497577161041
- 35 USC 102 Novelty (BERT): 0.5670528535494933
- Combined Prediction Score: 0.7863800672994431
- Mean Citation Score: 500.130458
- Max Citation Score: 507.59644
- Similarity Product: 348.7895998770689

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test